0001493152-21-004878.txt : 20210226
0001493152-21-004878.hdr.sgml : 20210226
20210226100447
ACCESSION NUMBER: 0001493152-21-004878
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210224
FILED AS OF DATE: 20210226
DATE AS OF CHANGE: 20210226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Walters Happy David
CENTRAL INDEX KEY: 0001779815
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39785
FILM NUMBER: 21684453
MAIL ADDRESS:
STREET 1: 165 DORADO BEACH EAST
CITY: DORADO
STATE: PR
ZIP: 00646
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LifeMD, Inc.
CENTRAL INDEX KEY: 0000948320
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 760238453
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 THIRD AVENUE, SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (866) 351-5907
MAIL ADDRESS:
STREET 1: 800 THIRD AVENUE, SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: CONVERSION LABS, INC.
DATE OF NAME CHANGE: 20180622
FORMER COMPANY:
FORMER CONFORMED NAME: Immudyne, Inc.
DATE OF NAME CHANGE: 20120514
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUDYNE INC
DATE OF NAME CHANGE: 19950720
4
1
ownership.xml
X0306
4
2021-02-24
0
0000948320
LifeMD, Inc.
LFMD
0001779815
Walters Happy David
C/O LIFEMD, INC, 800 THIRD AVENUE,
SUITE 2800
NEW YORK
NY
10022
1
0
0
0
Common Stock, par value $0.001
2021-02-24
4
A
0
1200000
0
A
1200000
I
Blue Horizon Consulting, LLC
Common Stock, par value $0.001
2021-02-24
4
J
0
800000
0
A
1336300
D
800,000 not then but now issuable shares deemed acquired from Issuer by Blue Horizon Consulting LLC in October 2020, as a result of Issuer's attainment of specified revenue targets at that time, and 400,000 not then but now issuable shares deemed acquired from Issuer by Blue Horizon Consulting LLC in December 2020, as a result of Issuer's attainment of specified revenue targets at that time, pursuant to a Consulting Agreement between Blue Horizon and Issuer (the "Agreement") in conjunction with Issuer's equity incentive performance share Award grant to Reporting Person pursuant to the Agreement, all as approved in advance by Issuer's Board of Directors. These transactions are exempt from Section 16(b) by virtue of SEC Rule 16b-3(d).
Shares issued for no consideration upon satisfaction of performance criteria underlying Award of performance shares.
Newly issued shares beneficially owned by Reporting Person, as sole owner and President of Blue Horizon Consulting LLC, and, hence, reported as owned indirectly by him.
Reflects distribution of 800,000 of Reporting Person's indirectly owned shares on October 17, 2020, by Blue Horizon Consulting LLC to Reporting Person as sole owner of Blue Horizon, resulting in a mere change of Reporting Person's ownership from indirect to direct. This distribution was not reportable when made, being only a change in form of ownership, with no change in Reporting Person's pecuniary interest and, therefore, exempt from reporting at time of distribution by SEC Rule 16a-13 and Exchange Act Release No. 34-37260, note 117 (1996).
Number of shares currently reported as directly owned by Reporting Person consists of the 800,000 shares previously reported as indirectly and now directly owned, plus the 536,300 shares previously reported as directly owned by Reporting Person in Form 4 filings prior to October 17, 2020.
/s/ Happy Walters
2021-02-26